开普检测(003008) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was CNY 48,199,791.31, representing a 7.88% increase compared to CNY 44,677,351.83 in the same period last year[5]. - Net profit attributable to shareholders was CNY 16,240,464.46, up 23.86% from CNY 13,111,670.01 year-over-year[5]. - The net profit excluding non-recurring gains and losses increased by 39.78% to CNY 14,462,757.70 from CNY 10,346,999.99 in the previous year[5]. - Total operating revenue for the current period reached ¥48,199,791.31, an increase of 3.7% compared to ¥44,677,351.83 in the previous period[18]. - Net profit for the current period was ¥16,240,464.46, representing a significant increase of 23.4% from ¥13,111,670.01 in the previous period[19]. - Basic and diluted earnings per share were both ¥0.16, compared to ¥0.13 in the prior period, reflecting a 23.1% increase[20]. Cash Flow and Liquidity - The company's cash flow from operating activities decreased by 17.77% to CNY 19,103,751.44, down from CNY 23,231,193.44 in the same period last year[5]. - Net cash flow from operating activities was ¥19,103,751.44, down 17.5% from ¥23,231,193.44 in the previous period[20]. - Cash and cash equivalents increased significantly by 314.38% to CNY 388,052,172.93 due to the redemption of some financial products[9]. - Cash and cash equivalents at the end of the period totaled ¥388,025,672.93, a decrease from ¥453,984,205.68 at the end of the previous period[22]. - Cash flow from investment activities generated a net inflow of ¥290,951,376.57, compared to ¥348,594,286.07 in the prior period, indicating a decrease of 16.5%[22]. Assets and Liabilities - Total assets at the end of Q1 2025 were CNY 1,143,485,140.53, a decrease of 1.14% from CNY 1,156,643,926.36 at the end of the previous year[5]. - Total liabilities decreased to ¥49,629,758.54 from ¥79,029,008.83, a reduction of approximately 37.2%[16]. - The company's total equity increased to ¥1,093,855,381.99 from ¥1,077,614,917.53, reflecting a growth of about 1.5%[17]. - Accounts receivable decreased slightly to ¥21,289,715.23 from ¥22,916,715.31, a decline of approximately 7.1%[15]. - Inventory decreased to ¥2,008,347.18 from ¥2,667,236.79, a reduction of about 24.7%[15]. Expenses and Investments - Total operating costs amounted to ¥31,457,486.52, up 6.0% from ¥29,665,755.82 in the prior period[18]. - The company reported a significant decrease in employee compensation payable from ¥15,710,516.28 to ¥4,128,014.41, a drop of approximately 73.8%[16]. - Research and development expenses increased to ¥2,943,454.37, up 21.1% from ¥2,429,052.01 in the previous period[18]. - The company reported a decrease in investment income to ¥2,061,905.20 from ¥3,675,993.23, a decline of 43.9%[18]. - The company plans to reinvest in financial products, with an investment cash outflow of CNY 110,000,000.00 during the quarter[10]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 9,610[12]. - The largest shareholder, Xuchang Kaipu Electric Research Institute Co., Ltd., holds 22.50% of shares, totaling 23,400,000 shares[12]. - The company has no preferred shareholders or significant changes in shareholder structure reported[13]. Government Support - The company received government subsidies amounting to CNY 84,738.19, which are closely related to its normal business operations[6]. - The company paid out CNY 15,600,000.00 in dividends during the quarter, reflecting a significant cash distribution to shareholders[10]. Financial Expenses - The company reported a 66.71% reduction in financial expenses, amounting to CNY -112,687.31 compared to CNY -338,499.12 in the previous year[10]. - The company recorded a decrease in tax expenses to ¥2,989,503.39 from ¥6,153,912.34, a reduction of 51.4%[19].